Skip to main content

Biomarin Pharmaceutical Inc 10-K for FY2025

Biomarin Pharmaceutical Inc (BMRN)

10-K 2026-02-26 For: 2025-12-31
View Original
Added on April 12, 2026

About this 10-K

Biomarin Pharmaceutical Inc filed this 10-K on February 26, 2026, covering the fiscal year ended December 31, 2025 (FY2025).

Headline figures

Fiscal year ended December 31, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$3.22B
up 12.9% from $2.85B a year earlier
Net income
$348.9M
down 18.3% from net income of $426.86M a year earlier
Diluted EPS
$1.80
down 18.6% from $2.21 a year earlier